Stefania Cheli

896 total citations
37 papers, 437 citations indexed

About

Stefania Cheli is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stefania Cheli has authored 37 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stefania Cheli's work include Drug Transport and Resistance Mechanisms (8 papers), HIV/AIDS drug development and treatment (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Stefania Cheli is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), HIV/AIDS drug development and treatment (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Stefania Cheli collaborates with scholars based in Italy, United States and Germany. Stefania Cheli's co-authors include Emilio Clementi, Felicia Stefania Falvella, Dario Cattaneo, Beatrice Bodega, Enrico Ginelli, Raffaella Meneveri, Sara Baldelli, Filippo Pietrantonio, Silvia Brunelli and Stefan O. Mueller and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Stefania Cheli

36 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Cheli Italy 12 181 105 61 55 43 37 437
Marianne Rodrigues Fernandes Brazil 12 149 0.8× 100 1.0× 29 0.5× 54 1.0× 23 0.5× 63 391
Ping Zheng China 8 166 0.9× 138 1.3× 33 0.5× 53 1.0× 21 0.5× 44 480
Martin Paton United Kingdom 8 370 2.0× 113 1.1× 24 0.4× 33 0.6× 20 0.5× 19 597
Tejaswi Kandula Australia 8 92 0.5× 147 1.4× 10 0.2× 91 1.7× 61 1.4× 21 438
Rajani Kaimal United States 11 129 0.7× 179 1.7× 25 0.4× 54 1.0× 36 0.8× 15 459
Jane D. Filie United States 8 206 1.1× 50 0.5× 20 0.3× 174 3.2× 20 0.5× 11 563
Randall W. Yatscoff Canada 9 113 0.6× 42 0.4× 14 0.2× 105 1.9× 56 1.3× 15 429
Alan M. Miller United States 15 98 0.5× 155 1.5× 21 0.3× 18 0.3× 26 0.6× 34 546
Jingky Lozano-Kühne United Kingdom 10 175 1.0× 53 0.5× 18 0.3× 33 0.6× 15 0.3× 22 437

Countries citing papers authored by Stefania Cheli

Since Specialization
Citations

This map shows the geographic impact of Stefania Cheli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Cheli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Cheli more than expected).

Fields of papers citing papers by Stefania Cheli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Cheli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Cheli. The network helps show where Stefania Cheli may publish in the future.

Co-authorship network of co-authors of Stefania Cheli

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Cheli. A scholar is included among the top collaborators of Stefania Cheli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Cheli. Stefania Cheli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheli, Stefania, Alessandro Torre, Marco Schiuma, et al.. (2024). NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study. Clinical Infectious Diseases. 81(1). 145–152. 1 indexed citations
2.
Maconi, Giovanni, et al.. (2024). Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication. Digestive and Liver Disease. 56(12). 2052–2059. 4 indexed citations
3.
Cheli, Stefania, et al.. (2023). Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping. Pharmacogenomics and Personalized Medicine. Volume 16. 739–746. 2 indexed citations
4.
Cheli, Stefania, Francesca Penagini, Gianvincenzo Zuccotti, et al.. (2023). Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges. Pharmaceutics. 15(7). 1834–1834. 5 indexed citations
5.
Cheli, Stefania, et al.. (2021). In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5. Biomedicine & Pharmacotherapy. 139. 111631–111631. 9 indexed citations
6.
Cheli, Stefania, Sara Baldelli, Annalisa De Silvestri, et al.. (2021). ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment. The Pharmacogenomics Journal. 21(5). 586–593. 5 indexed citations
7.
Carnovale, Carla, Francesca Parisi, Vera Battini, et al.. (2021). The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacological Research. 171. 105786–105786. 3 indexed citations
8.
Verde, Nicla La, Giovanni Casazza, Stefania Cheli, et al.. (2021). Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients. The Pharmacogenomics Journal. 21(4). 491–497. 3 indexed citations
9.
Cheli, Stefania, et al.. (2020). DNA extraction from fresh and frozen plasma: an alternative for real-time PCR genotyping in pharmacogenetics. Molecular Biology Reports. 47(8). 6451–6455. 5 indexed citations
10.
Casetta, Cecilia, Stefania Cheli, Sara Baldelli, et al.. (2019). Pharmacogenetic variants in bipolar disorder with elevated treatment resistance and intolerance: Towards a personalized pattern of care. Bipolar Disorders. 21(3). 288–291. 4 indexed citations
11.
Pileri, P., M. Mazzocco, Chiara Mandò, et al.. (2019). Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure. Frontiers in Pediatrics. 7. 309–309. 15 indexed citations
12.
Nichetti, Federico, Felicia Stefania Falvella, Rosalba Miceli, et al.. (2019). Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?. The Pharmacogenomics Journal. 19(5). 465–472. 16 indexed citations
13.
Giacomelli, Andrea, Agostino Riva, Felicia Stefania Falvella, et al.. (2018). Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infectious Diseases. 18(1). 556–556. 14 indexed citations
14.
Rafaniello, Concetta, Maurizio Sessa, Francesca Futura Bernardi, et al.. (2017). The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. The Pharmacogenomics Journal. 18(3). 422–430. 41 indexed citations
15.
Falvella, Felicia Stefania, Susan Marelli, Stefania Cheli, et al.. (2016). Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?. Drug Metabolism and Personalized Therapy. 31(3). 157–163. 4 indexed citations
16.
17.
Lombardi, Andrea, Simona Landonio, C. Magni, et al.. (2015). <b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology. 96(3-4). 163–166. 1 indexed citations
18.
Pellegrino, Paolo, Felicia Stefania Falvella, Valentina Perrone, et al.. (2014). The first steps towards the era of personalised vaccinology: predicting adverse reactions. The Pharmacogenomics Journal. 15(3). 284–287. 16 indexed citations
19.
Cheli, Stefania, Stéphanie François, Beatrice Bodega, et al.. (2011). Expression Profiling of FSHD-1 and FSHD-2 Cells during Myogenic Differentiation Evidences Common and Distinctive Gene Dysregulation Patterns. PLoS ONE. 6(6). e20966–e20966. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Rodrigues Fernandes Breakdown of academic impact, for papers by Ping Zheng Breakdown of academic impact, for papers by Martin Paton Breakdown of academic impact, for papers by Tejaswi Kandula Breakdown of academic impact, for papers by Rajani Kaimal Breakdown of academic impact, for papers by Jane D. Filie Breakdown of academic impact, for papers by Randall W. Yatscoff Breakdown of academic impact, for papers by Alan M. Miller Breakdown of academic impact, for papers by Jingky Lozano-Kühne
Rankless by CCL
2026